Clinical Trials Browser

Phase 1 × Terminated × AZD4547 × Clear all

NCT00979134 2019-03-15

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

Phase 1 Terminated

95 enrolled 19 charts

Neoplasms